Zero revenue is disturbing and I would be cautious as an investor here, but I do think CBIS has the potential to come up with a drug and that could get them rolling. However, so far all they've added are directors and some research. CBIS is a possible takeover candidate if they actually come up with something, but they're now nearing $100 million lost since starting.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.